Cargando…

Prolonged dual antiplatelet therapy in stable coronary disease: comparative observational study of benefits and harms in unselected versus trial populations

Objective To estimate the potential magnitude in unselected patients of the benefits and harms of prolonged dual antiplatelet therapy after acute myocardial infarction seen in selected patients with high risk characteristics in trials. Design Observational population based cohort study. Setting PEGA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Timmis, A, Rapsomaniki, E, Chung, S C, Pujades-Rodriguez, M, Moayyeri, A, Stogiannis, D, Shah, A D, Pasea, L, Denaxas, S, Emmas, C, Hemingway, H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group Ltd. 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916922/ https://www.ncbi.nlm.nih.gov/pubmed/27334486 http://dx.doi.org/10.1136/bmj.i3163

Ejemplares similares

Personalising the decision for prolonged dual antiplatelet therapy: development, validation and potential impact of prognostic models for cardiovascular events and bleeding in myocardial infarction survivors
por: Pasea, Laura, et al.
Publicado: (2017)

Socioeconomic Deprivation and the Incidence of 12 Cardiovascular Diseases in 1.9 Million Women and Men: Implications for Risk Prediction and Prevention
por: Pujades-Rodriguez, Mar, et al.
Publicado: (2014)

Time spent at blood pressure target and the risk of death and cardiovascular diseases
por: Chung, Sheng-Chia, et al.
Publicado: (2018)

Using big data from health records from four countries to evaluate chronic disease outcomes: a study in 114 364 survivors of myocardial infarction
por: Rapsomaniki, Eleni, et al.
Publicado: (2016)

Heterogeneous associations between smoking and a wide range of initial presentations of cardiovascular disease in 1 937 360 people in England: lifetime risks and implications for risk prediction
por: Pujades-Rodriguez, Mar, et al.
Publicado: (2015)

How Does Cardiovascular Disease First Present in Women and Men?: Incidence of 12 Cardiovascular Diseases in a Contemporary Cohort of 1 937 360 People
por: George, Julie, et al.
Publicado: (2015)

Depression as a Risk Factor for the Initial Presentation of Twelve Cardiac, Cerebrovascular, and Peripheral Arterial Diseases: Data Linkage Study of 1.9 Million Women and Men
por: Daskalopoulou, Marina, et al.
Publicado: (2016)

Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1·9 million people
por: Shah, Anoop Dinesh, et al.
Publicado: (2015)

Prognostic models for stable coronary artery disease based on electronic health record cohort of 102 023 patients
por: Rapsomaniki, Eleni, et al.
Publicado: (2014)

Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million people
por: Rapsomaniki, Eleni, et al.
Publicado: (2014)

Bleeding in cardiac patients prescribed antithrombotic drugs: electronic health record phenotyping algorithms, incidence, trends and prognosis
por: Pasea, Laura, et al.
Publicado: (2019)

Models for mortality require tailoring in the context of the COVID-19 pandemic – Authors' reply
por: Banerjee, Amitava, et al.
Publicado: (2020)

Associations between polymyalgia rheumatica and giant cell arteritis and 12 cardiovascular diseases
por: Pujades-Rodriguez, Mar, et al.
Publicado: (2016)

Ethnicity and the first diagnosis of a wide range of cardiovascular diseases: Associations in a linked electronic health record cohort of 1 million patients
por: George, Julie, et al.
Publicado: (2017)

Rheumatoid Arthritis and Incidence of Twelve Initial Presentations of Cardiovascular Disease: A Population Record-Linkage Cohort Study in England
por: Pujades-Rodriguez, Mar, et al.
Publicado: (2016)

Benefits and risks of antiplatelet medication in hemodynamically stable adult moyamoya disease
por: Pang, Chang Hwan, et al.
Publicado: (2021)

Benefits and Harms of Extending the Duration of Dual Antiplatelet Therapy after Percutaneous Coronary Intervention with Drug-Eluting Stents: A Meta-Analysis
por: Kwok, Chun Shing, et al.
Publicado: (2014)

Obesity during the COVID-19 pandemic: both cause of high risk and potential effect of lockdown? A population-based electronic health record study
por: Katsoulis, M., et al.
Publicado: (2021)

Development of a risk score for predicting the benefit versus harm of extending dual antiplatelet therapy beyond 6 months following percutaneous coronary intervention for stable coronary artery disease
por: Witberg, Guy, et al.
Publicado: (2019)

Prolonged dual antiplatelet therapy for Chinese ACS patients undergoing emergency PCI with drug-eluting stents: Benefits and risks
por: Zhang, Yong, et al.
Publicado: (2023)

Elevated plasma triglyceride concentration and risk of adverse clinical outcomes in 1.5 million people: a CALIBER linked electronic health record study
por: Patel, Riyaz S., et al.
Publicado: (2022)

Clopidogrel discontinuation after acute coronary syndromes: frequency, predictors and associations with death and myocardial infarction—a hospital registry-primary care linked cohort (MINAP–GPRD)
por: Boggon, Rachael, et al.
Publicado: (2011)

An electronic health records cohort study on heart failure following myocardial infarction in England: incidence and predictors
por: Gho, Johannes M I H, et al.
Publicado: (2018)

Association between clinical presentations before myocardial infarction and coronary mortality: a prospective population-based study using linked electronic records
por: Herrett, Emily, et al.
Publicado: (2014)

Benefit and Risk of Prolonged Dual Antiplatelet Therapy After Percutaneous Coronary Intervention With Drug-Eluting Stents in Patients With Elevated Lipoprotein(a) Concentrations
por: Cui, Kongyong, et al.
Publicado: (2021)

Short vs prolonged dual antiplatelet treatment upon endovascular stenting of peripheral arteries
por: Kronlage, Mariya, et al.
Publicado: (2017)

Identifying subtypes of chronic kidney disease with machine learning: development, internal validation and prognostic validation using linked electronic health records in 350,067 individuals
por: Dashtban, Ashkan, et al.
Publicado: (2023)

Prolonged double antiplatelet therapy vs association of antiplatelet and low dose of anticoagulant therapy: PEGASUS or COMPASS?
por: Brunetti, Natale Daniele, et al.
Publicado: (2019)

Type and timing of heralding in ST-elevation and non-ST-elevation myocardial infarction: an analysis of prospectively collected electronic healthcare records linked to the national registry of acute coronary syndromes
por: Herrett, Emily, et al.
Publicado: (2013)

Expert position paper on prolonged dual antiplatelet therapy in secondary prevention following myocardial infarction
por: Weiss, Thomas W., et al.
Publicado: (2016)

Influenza Infection and Risk of Acute Myocardial Infarction in England and Wales: A CALIBER Self-Controlled Case Series Study
por: Warren-Gash, Charlotte, et al.
Publicado: (2012)

Metformin use and cardiovascular outcomes after acute myocardial infarction in patients with type 2 diabetes: a cohort study
por: Bromage, Daniel I., et al.
Publicado: (2019)

Cancer experience in the relatives of an unselected series of breast cancer patients.
por: Teare, M. D., et al.
Publicado: (1994)

Prevalence and predictors of dual antiplatelet therapy prolongation beyond one year in patients with acute coronary syndrome
por: Patti, Giuseppe, et al.
Publicado: (2017)

Short dual antiplatelet therapy and dual antiplatelet therapy de-escalation after primary percutaneous intervention: For whom and how
por: Muthspiel, Marie, et al.
Publicado: (2022)

Clinical academic research in the time of Corona: A simulation study in England and a call for action
por: Banerjee, Amitava, et al.
Publicado: (2020)

Balance of benefits and harms of different blood pressure targets in people with multiple chronic conditions: a quantitative benefit-harm assessment
por: Aschmann, Hélène E, et al.
Publicado: (2019)

Association between clinically recorded alcohol consumption and initial presentation of 12 cardiovascular diseases: population based cohort study using linked health records
por: Bell, Steven, et al.
Publicado: (2017)

Data Resource Profile: Cardiovascular disease research using linked bespoke studies and electronic health records (CALIBER)
por: Denaxas, Spiros C, et al.
Publicado: (2012)

Cancer immunotherapy: Benefit and harm?
por: Characiejus, Dainius
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_dgk9qnmoukkojd0cl9s6fni2e0